hotspot -WSS

hotspot

author：Wikipedia 2025-10-01 00:47:35 - browse：9

UCB website -- health policy coverage from STAT — Adobe

WASHINGTON — UCB left BIO at the end of 2023, the second major member company to exit after Pfizer pulled out as well.

UCB, headquartered in Belgium, decided not to renew its BIO membership after a routine evaluation of its engagement in trade associations, said company spokesperson Erica Puntel.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

Pfizer, whose departure STAT reported first, was listed on BIO’s website as a sponsor at one of the group’s highest levels. Pfizer bought Global Blood Therapeutics, which current BIO Board Chair Ted Love led to the approval of a drug to treat sickle cell disease, in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Health AI adoption puts security, privacy startups on investors' radar

Wikipedia

WSS

Despite FDA concern, risk that CAR

Cigna, Humana reportedly in talks to merge

Organ aging and disease risk measured by new blood test

Colonoscopy prep: Liquid

Asbestos, a deadly carcinogen, banned by EPA

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

entertainment

hotspot

Sign up for D.C. Diagnosis

Wikipedia

After affirmative action ruling, medical educators look to 'holistic review'

Gene editing the human germline: What are the risks?

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Bluebird, CVS, Contineum

The cancer drug shortage isn’t new — and neither are the solutions

Creating egg and sperm cells from stem cells raises ethical issues

Activists slam private health insurers over coverage restrictions

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

hotspot

Readout Newsletter: Bluebird, CVS, Contineum

Organ aging and disease risk measured by new blood test

30 years of 'Listening to Prozac'

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Virtual Event: March of the Biosimilars

Positive childhood experiences can help future health

hotspot

hotspot

Wikipedia

leisure time